Lurasidone-D8 | CAS 1132654-54-6 - Request Quote
Lurasidone-D8
| SZ CAT No: | SZ-L035D01 |
| CAS No | 1132654-54-6 |
| Mol.F. | C28H28D8N4O2S |
| Mol.Wt. | 500.7 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Lurasidone-D8 is chemically (3aR,4S,7R,7aS)-2-(((1R,2R)-2-((4-(benzo[d]isothiazol-3-yl)piperazin-1-yl-2,2,3,3,5,5,6,6-d8)methyl)cyclohexyl)methyl)hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione. Lurasidone-D8 is supplied with detailed characterization data compliant with regulatory guideline. Lurasidone-D8 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lurasidone.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1132654-54-6
Purchase 1132654-54-6
Order 1132654-54-6
Enquire 1132654-54-6
price of 1132654-54-6
1132654-54-6 Supplier
1132654-54-6 Manufacturer
1132654-54-6 Exporter
buy high quality Lurasidone-D8
Purchase Lurasidone-D8
Lurasidone-D8 suppliers
Lurasidone-D8 manufacturers
Lurasidone-D8 price
Order Lurasidone-D8
Enquire Lurasidone-D8
Lurasidone-D8 cost
Lurasidone-D8 Supplier
Lurasidone-D8 Distributor
Lurasidone-D8 for Method Validation
Lurasidone Reference Standard
Lurasidone-D8 for ANDA Filing
Lurasidone-D8 for Forced Degradation Studies
Lurasidone-D8 Identification Standards
Lurasidone-D8 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


